Filing Details
- Accession Number:
- 0001209191-10-049463
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-10-05 19:57:55
- Reporting Period:
- 2010-10-01
- Filing Date:
- 2010-10-05
- Accepted Time:
- 2010-10-05 19:57:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1180262 | Herbalife Ltd. | HLF | Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1434625 | Steve Yair Henig | 800 W. Olympic Boulevard, #406 Los Angeles CA 90015 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-10-01 | 10,000 | $40.25 | 19,776 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-10-01 | 8,196 | $60.84 | 11,580 | No | 4 | D | Direct | |
Common Stock | Disposition | 2010-10-05 | 1,804 | $61.00 | 9,776 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | D | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Appreciation Rights | Disposition | 2010-10-01 | 10,000 | $0.00 | 10,000 | $40.25 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
16,083 | 2017-05-29 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 13, 2010.
- Consists of stock appreciation rights granted under the Herbalife Ltd. 2005 Stock Incentive Plan, of which 20% vested on May 29, 2008, 20% vested on May 29, 2009 and the remaining 60% vested on May 29, 2010.